Skip to content
ClinCalc Pro
Menu
Opioid Antagonist

Naloxone

Brand names: Narcan, Prenoxad (intranasal)

Naloxone is a pure opioid antagonist used to reverse opioid-induced respiratory depression and sedation in suspected or confirmed opioid overdose, available in parenteral and intranasal formulations including take-home kits.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It competitively displaces opioids from mu-opioid receptors, rapidly reversing their central depressant effects, but has a short duration of action.

Prescribing in practice

  • Its effect can wear off before that of long-acting opioids, so patients must be observed and may need repeated doses or an infusion to prevent re-narcotisation.
  • In opioid-dependent patients it can precipitate acute withdrawal with agitation, pain and cardiovascular effects, so titrate carefully where the aim is to restore adequate breathing.
  • Always call for emergency help and provide supportive airway and ventilatory care alongside administration.

Monitoring

Monitor conscious level, respiratory rate and oxygen saturation continuously, watching for recurrence of opioid effect as naloxone wears off.

Counselling the patient

  • After giving naloxone, always seek emergency medical help because the opioid effect can return.
  • Lay rescuers should be shown how to recognise overdose and administer the kit.
  • Stay with the person and be prepared to give a further dose if breathing deteriorates again.

Evidence & guidelines

Naloxone is the established antidote for opioid overdose, and take-home naloxone programmes are supported by UK public health guidance.

Reference: TOXBASE (UK National Poisons Information Service); NICE Evidence on Naloxone; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.